Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...
These are known as disease-modifying treatments and have been licensed for private use ... making a big difference to their quality of life Aim to maintain a person’s ability to carry out daily tasks ...